Patent US4957941A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4957941A Expired / Lapsed US ⏱️ 0.0 years remaining

Anti-spasmdoic agents having an acetylenic bond

Assignee: United Pharmaceuticals Inc
•
Filing: 1990-01-09
•
Granted: 1990-09-18
•
Expires: 2010-01-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A new class of anti-spasmodic compounds having two branch chains is provided. The compounds have the general formula: ##STR1## where Y is H or OH; j is an integer from 0 to 4; k is an integer from 0 to 4, and wherein m is an integer from 1 to 4; n is an integer from 1 to 4; p is an integer from 1 to 4; and X may be nonexistent or may be O, S, NH or CH 2 or salts thereof, but when X is nonexistent the terminal group in which both the n-chain and the p-chain is a methyl group. ##STR2## The reaction was performed under reflux condensation. Following the reaction, which was usually complete within a few hours, the acid chlorides were vacuum distilled and reacted with a thiol compound as described above. The compounds of this invention are anti-muscarinic agents (cholinergic-muscarinic receptor antagonists) which inhibit the actions of acetylcholine on autonomic effectors innervated by postganglionic cholinergic nerves as well as on smooth muscle that lacks cholinergic innervation. Since a major component of parasympathetic control of smooth muscle occurs via muscarinic receptors, these compounds are effective as modifiers of smooth muscle activity. Thiphenamil hydrochloride has been shown to decrease spasm of the gastrointestinal tract, biliary tract, ureter and uterus without producing characteristic atropinic side effects on salivary and sweat glands, GI glands, the eye or the cardiovascular system. This invention results in compounds which are as efficacious as thiphenamil hydrochloride, or more so, in relaxing various smooth muscle systems while at the same time demonstrating thiphenamil hydrochloride's lack of associated side-effects.

Inventors

  • 👤 William M. Davis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 12:05
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/08; C07D295/084

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 94 words
A compound of the formula ##STR8## where Y is H or OH; j is an integer from 0 to 4; k is an integer from 0 to 4; m is an integer from 1 to 4; n is an integer from 1 to 4; p is an integer from 1 to 4; and X may be nonexistent or may be O, S, NH or CH 2 or salts thereof, but when X is nonexistent the terminal group in both the n-chain and the p-chain is a methyl group, whereby the --N radical is ##STR9##
Claim 2
Dependent Claim 94 words
A compound of the formula ##STR8## where Y is H or OH; j is an integer from 0 to 4; k is an integer from 0 to 4; m is an integer from 1 to 4; n is an integer from 1 to 4; p is an integer from 1 to 4; and X may be nonexistent or may be O, S, NH or CH 2 or salts thereof, but when X is nonexistent the terminal group in both the n-chain and the p-chain is a methyl group, whereby the --N radical is ##STR9##
Claim 3
Dependent Claim 17 words
The compound as defined in claim 1, wherein j=0, k=1, m=1, n=2, p=2 and X is nonexistent.
Claim 4
Independent Claim 113 words
A method of treating a patient suffering smooth muscle spasm comprising administering to the patient an effective amount of a compound having the formula: ##STR10## where Y is H or OH; j is an integer from 0 to 4; k is an integer from 0 to 4; m is an integer from 1 to 4; n is an integer from 1 to 4; p is an integer from 1 to 4; and X may be nonexistent or may be O, S, NH, or CH 2 or salts thereof, but when X is nonexistent the terminal group in both the n-chain and the p-chain is a methyl group, whereby the --N radical is ##STR11##
Claim 5
Independent Claim 113 words
A method of treating a patient suffering smooth muscle spasm comprising administering to the patient an effective amount of a compound having the formula: ##STR10## where Y is H or OH; j is an integer from 0 to 4; k is an integer from 0 to 4; m is an integer from 1 to 4; n is an integer from 1 to 4; p is an integer from 1 to 4; and X may be nonexistent or may be O, S, NH, or CH 2 or salts thereof, but when X is nonexistent the terminal group in both the n-chain and the p-chain is a methyl group, whereby the --N radical is ##STR11##
Claim 6
Dependent Claim 27 words
The method as defined in claim 3, wherein the compound is administered in a dosage of from 0.01 to about 0.15 mg/kg of body weight per day.
Claim 7
Dependent Claim 28 words
The method as defined in claim 3, wherein the compound is administered in a dosage of from about 0.015 to about 0.115 mg/kg of body weight per day.
Claim 8
Dependent Claim 28 words
The method as defined in claim 3, wherein the compound is administered in a dosage of from about 0.03 to about 0.07 mg/kg of body weight per day.
Claim 9
Dependent Claim 17 words
The method as defined in claim 3, wherein the compound is combined with a pharmaceutically acceptable carrier.
Claim 10
Dependent Claim 17 words
The compound as defined in claim 1, wherein j=0, k=2, m=2, n=2, p=2 and X is nonexistent.
Claim 11
Dependent Claim 19 words
The compound as defined in claim 1, wherein j=0, k=1, m=1, n=2, p=2 and X is CH 2 .
Claim 12
Dependent Claim 17 words
The compound as defined in claim 1, wherein j=0, k=1, m=1, n=2, p=2 and X is oxygen.
Claim 13
Dependent Claim 17 words
The compound as defined in claim 1, wherein j=0, k=1, m=1, n=2, p=2 and X is S.
Claim 14
Dependent Claim 17 words
The compound as defined in claim 1, wherein j=0, k=1, m=1, n=2, p=2 and X is NH.
Claim 15
Dependent Claim 17 words
The compound as defined in claim 1, wherein j=0, k=1, m=1, n=3, p=2 and X is nonexistent.
Claim 16
Dependent Claim 17 words
The compound as defined in claim 1, wherein j=0, k=1, m=1, n=4, p=3 and X is nonexistent.
Claim 17
Dependent Claim 17 words
The compound as defined in claim 1, wherein j=0, k=1, m=1, n=1, p=1 and X is nonexistent.
Claim 18
Dependent Claim 32 words
The compound as defined in claim 1, wherein j=0, k=1, m=1, n=1, p=1, X is nonexistent and the terminal group in both the n chain and the p chain are bonded together.
Claim 19
Dependent Claim 10 words
The compound defined in claim 1, wherein Y is H.
Claim 20
Dependent Claim 10 words
The compound defined in claim 1, wherein Y is OH.

References Cited (Backward Citations)

GB940540A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-09-17 1994-03-19 1994-09-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-09-17 1998-03-19 1998-09-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-09-17 2002-03-19 2002-09-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag